Medical News Today - Research Provides New Clues For Schizophrenia Drug Development

New York, NY
 – August 14, 2012  –– 

Around one percent of the world's population suffers from schizophrenia. However, around 30 percent of patients do not respond to current drugs for treating schizophrenia. In a study published online in Nature Neuroscience, researchers of the Mount Sinai School of Medicine may now have discovered the reasons for this. The discovery opens the door for a new class of drugs that can help in treating this devastating mental illness. Leading researcher Javier Gonzalez-Maeso, PhD, Assistant Professor of Psychiatry and Neurology at Mount Sinai School of Medicine, said: "These results are groundbreaking because they show that drug resistance may be caused by the very medications prescribed to treat schizophrenia, when administered chronically."

- Dr. Javier Gonzalez-Maeso, Assistant Professor, Psychiatry, Neurology, Mount Sinai School of Medicine

Learn more